Abstract: The disclosure refers to a road construction machine, adapted in particular in the form of a road paver or a feeder vehicle for a road paver. According to the disclosure, the road construction machine comprises a first and/or a second air barrier device adapted to shield a driver and/or an operator of the road construction machine. Furthermore, the disclosure refers to a corresponding method for generating an air flow during operation of a road construction machine in order to shield a driver and/or an operator from vapors and/or aerosols rising during operation of the road construction machine.

Abstract: A stator of an electrical coolant drive includes a stator assembly having a number of stator teeth that are provided with coils of a multi-phase stator winding, and a contact device disposed on the stator assembly on an end side for interconnecting the coils with the phase connections. A deflection region is provided on the outer periphery of the contact device in the region of an inlet of the coolant drive for a fluid flowing in through the inlet. A contact device and an electric coolant drive are also provided.

Abstract: A screw element of a ball screw mechanism includes a lead screw which, at an axial end, is joined to a rod element using a friction welding process. In order to improve the friction-welded joint, prior to the friction welding process, the lead screw has a circumferential groove on the end face facing the rod element.

Abstract: A screw element of a ball screw mechanism includes a lead screw which, at an axial end, is joined to a rod element using a friction welding process. In order to improve the friction-welded joint, prior to the friction welding process, the lead screw has a circumferential groove on the end face facing the rod element.

Abstract: A system for triggering an imaging process, includes: a processing unit that is configured for: obtaining first information regarding a state of a device; processing the first information to determine if the state of the device satisfies a first pre-defined criterion; and generating a signal to cause an imaging process to begin based at least in part on a result from the act of processing. A system for triggering an imaging process, includes: a processing unit that is configured for: obtaining first information, the first information comprising dose information; processing the first information to determine if a first pre-defined criterion is satisfied; and generating a signal to cause an imaging process to begin based at least in part on a result from the act of processing.

Abstract: A focused ion beam device is described comprising a gas field ion source with an analyzer for analyzing and classifying the structure of a specimen, a controller for controlling and/or modifying the structure of the specimen according to the analysis of the analyzer, an emitter tip, the emitter tip has a base tip comprising a first material and a supertip comprising a material different from the first material, wherein the supertip is a single atom tip and the base tip is a single crystal base tip. Furthermore, the focused ion beam device has a probe current control and a sample charge control. A method of operating a focused ion beam device is provided comprising applying a voltage between a single emission center of the supertip and an electrode, supplying gas to the emitter tip, analyzing and classifying the structure of a specimen, and controlling the structure of the specimen.

Abstract: A charged particle beam device is described. The device includes an emitter unit including an emitter tip; a voltage supply unit adapted for providing a stable voltage to generate a stable extraction field at the emitter tip; a pulsed voltage supply member adapted for providing a pulsed voltage to generate a pulsed extraction field on top of the stable extraction field; a measuring unit for measuring an emitter characteristic; and a control unit adapted for receiving a signal from the measuring unit and for control of the pulsed voltage supply member.

Abstract: A method of operating a focused ion beam device for emitting during operation a focused ion beam including ions of a gas generated at a first partial pressure, comprising cleaning an emitter tip positioned in an emitter tip region of the focused ion beam device, the cleaning comprises introducing the gas into the emitter tip region such that the gas has a second partial pressure of at least two times the first pressure. Further, a focused ion beam device is provided, comprising a gas field emitter tip (13) in an emitter tip region emitting an ion beam including ions of a gas, a gas inlet for supplying a gas with different pressures (110), a gas outlet (120), a pressure measurement device for measuring the pressure in the emitter tip region and a control unit (130) for controlling switching between an operation mode and a cleaning mode, further controlling the pressures in the emitter tip region and being connected to the pressure measurement device.

Abstract: The invention relates to a solar panel assembly and a method of making thereof. The solar panel assembly includes a solar panel having a non-light receiving surface and a support member. The support member is attached to the non-light receiving surface of the solar panel by means of a hot melt moisture curable composition.

Abstract: The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt.

Abstract: A method of preparing an ultra sharp tip, in particular a single atom tip, is provided, comprising providing a tip having a shank, an apex, and a coating covering the shank and the apex; locally removing the coating from the apex by field evaporation; and partially or fully restoring the coating at the apex.

Abstract: A polysulphide-containing two-component adhesive/sealant consists of a binder component and a curing agent component, and is suitable for use as the secondary seal in the edge region of the insulating glass and/or for bonding the insulating glass unit in the frame or window sash of a window unit in a friction locked manner according to the process of rebate base bonding or back bedding.

Abstract: A focused ion beam device is described comprising a gas field ion source with an analyzer for analyzing and classifying the structure of a specimen, a controller for controlling and/or modifying the structure of the specimen according to the analysis of the analyzer, an emitter tip, the emitter tip has a base tip comprising a first material and a supertip comprising a material different from the first material, wherein the supertip is a single atom tip and the base tip is a single crystal base tip. Furthermore, the focused ion beam device has a probe current control and a sample charge control. A method of operating a focused ion beam device is provided comprising applying a voltage between a single emission centre of the supertip and an electrode, supplying gas to the emitter tip, analyzing and classifying the structure of a specimen, and controlling the structure of the specimen.

Abstract: A method of operating a focused ion beam device for emitting during operation a focused ion beam including ions of a gas generated at a first partial pressure, comprising cleaning an emitter tip positioned in an emitter tip region of the focused ion beam device, the cleaning comprises introducing the gas into the emitter tip region such that the gas has a second partial pressure of at least two times the first pressure. Further, a focused ion beam device is provided, comprising a gas field emitter tip (13) in an emitter tip region emitting an ion beam including ions of a gas, a gas inlet for supplying a gas with different pressures (110), a gas outlet (120), a pressure measurement device for measuring the pressure in the emitter tip region and a control unit (130) for controlling switching between an operation mode and a cleaning mode, further controlling the pressures in the emitter tip region and being connected to the pressure measurement device.

Abstract: A charged particle beam device is described. The device includes an emitter unit including an emitter tip; a voltage supply unit adapted for providing a stable voltage to generate a stable extraction field at the emitter tip; a pulsed voltage supply member adapted for providing a pulsed voltage to generate a pulsed extraction field on top of the stable extraction field; a measuring unit for measuring an emitter characteristic; and a control unit adapted for receiving a signal from the measuring unit and for control of the pulsed voltage supply member.

Abstract: A mixture of at least two thermoplastic particles having reactive grups which when melted and mixed react to form a high molecular weight polymer. The blend of particles when molten is particularly useful in forming double insulating glass or plastic panels.

Abstract: The invention relates to a dispersion suitable for use as coating agent and binder for pharmaceutical forms, having a solids content of 10–70% by weight consisting of a) from 90 to 99% by weight of a methacrylate copolymer consisting of at least 90% by weight of (meth)acrylate monomers containing neutral radicals and having a glass transition temperature Tg of from ?20° C. to +20° C. as determined by the DSC method, and b) 1–10% by weight of a nonionic emulsifier having an HLB of from 15.2 to 17.3.

Abstract: The use of benzoate plasticizers in two-component insulating glass adhesives/sealants based on polysulfide polymers or polymercaptan polymers enables simpler production due to the low viscosity thereof. Improved miscibility of the two components and an improved rate of curing are observed. In addition, the use of phthalate plasticizers, which may possibly cause an endocrinal effect in humans and animals, is avoided.

Abstract: The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt.

Abstract: Method for isolating and purifying nucleic acids and/or oligonucleotides from a biological sample, the use of the isolated or purified nucleic acid and/or oligonucleotide for transfecting cells and also for the production of an agent for the treatment of genetic disorders, a composition suitable for the isolation or purification method and also the use of potassium acetate and a silica gel-like support material for isolating endotoxin-free nucleic acids and/or oligonucleotides or nucleic acids and/or oligonucleotides with reduced endotoxin content.